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Abstract
Background: In malaria endemic countries of sub-Saharan Africa, many children develop severe anaemia due to
previous and current malaria infections. After blood transfusions and antimalarial treatment at the hospital they are
usually discharged without any follow-up. In the post-discharge period, these children may contract new malaria
infections and develop rebound severe anaemia. A randomised placebo-controlled trial in Malawi showed 31%
reduction in malaria- and anaemia-related deaths or hospital readmissions among children under 5 years of age
given antimalarial drugs for 3 months post-discharge. Thus, post-discharge malaria chemoprevention (PMC) may
provide substantial protection against malaria and anaemia in young children living in areas of high malaria
transmission. A delivery implementation trial is currently being conducted in Malawi to determine the optimal
strategy for PMC delivery. In the trial, PMC is delivered through community- or facility-based methods with or
without the use of reminders via phone text message or visit from a Health Surveillance Assistant. This paper
describes the acceptance of PMC among caregivers.
Methods: From October to December 2016, 30 in-depth interviews and 5 focus group discussions were conducted
with caregivers of children who recently completed the last treatment course in the trial. Views on the feasibility of
various delivery methods and reminder strategies were collected. The interviews were transcribed verbatim,
translated to English, and coded using the software programme NVivo.
Results: Community-based delivery was perceived as more favourable than facility-based delivery due to easy
home access to drugs and fewer financial concerns. Many caregivers reported lack of visits from Health Surveillance
Assistants and preferred text message reminders sent directly to their phones rather than waiting on these visits.
Positive attitudes towards active use of health cards for remembering treatment dates were especially evident.
Additionally, caregivers shared positive experiences from participation in the programme and described
dihydroartemisinin-piperaquine as a safe and effective antimalarial drug that improved the health and well-being of
their children.
Conclusions: Post-discharge malaria chemoprevention given to children under the age of 5 previously treated for
severe anaemia is highly accepted among caregivers. Caregivers prefer community-based delivery with use of
health cards as their primary tool of reference.
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Background
In sub-Saharan countries many children develop severe
anaemia as a result of previous and current malaria in-
fections. Standard treatment at the hospital is blood
transfusion and a short treatment course of antimalarial
drugs. After an episode of severe anaemia, the red blood
cell production needs at least 6 weeks to recover. If chil-
dren experience recrudescent malaria infections or con-
tract new infections in this period, the haematological
recovery is further prolonged and they are at risk of de-
veloping rebound severe anaemia [1].
No specific strategy of follow-up care for children in the
post-discharge period has been established. In 2012, our re-
search group conducted a randomised placebo-controlled
trial in Malawi where children under 5 years of age with se-
vere anaemia received post-discharge malaria chemopre-
vention (PMC) of artemether lumefantrine (AL) for
3 months [2]. By 6 months, 31% of deaths or hospital read-
missions due to severe malaria or anaemia were prevented.
These findings suggest that PMC may provide a substantial
protection against malaria- and anaemia related morbidity
and mortality among young children living in malaria en-
demic areas. Therefore, to inform policy and guide imple-
mentation, a delivery implementation trial is currently
being conducted in Malawi to determine the optimal PMC
delivery strategy (ClinicalTrials.gov NCT02721420).
Children enrolled in the trial are 4–59 months old,
clinically stable with body weight of 5 kg or above,
and have completed at least one blood transfusion.
Study participants are required to receive the antimal-
arial drug dihydroartemisinin-piperaquine (DHP) at 2,
6 and 10 weeks post-discharge. Each treatment course
lasts for 3 days and caregivers are instructed to dis-
solve the drugs in water before giving it to their chil-
dren to drink. In previous intervention studies, DHP
is reported to be a well-tolerated, long-acting and ef-
fective antimalarial drug with few serious adverse
events [3–5].
Participants in the PMC trial are randomly allocated
to one of five study arms, where the delivery strategies
are either community- or facility-based (Table 1). In the
community-based study arms (1 + 2 + 3) caregivers re-
ceive all drugs at the hospital before their children are
discharged from the hospital. Caregivers are expected to
remember treatment dates with the following aids:
Arm 1. Exclusive use of the child’s health card.
Arm 2. Text message reminder.
Arm 3. Visit from Health Surveillance Assistant.
In the facility-based study arms (4 + 5) caregivers are
instructed to collect drugs at the hospital for each treat-
ment course. They are expected to remember dates for
drug collection with the following aids:
Arm 4. Exclusive use of the child’s health card.
Arm 5. Text message reminder.
The overarching objective is to determine which strat-
egy is best suited for large-scale and long-time imple-
mentation of PMC in areas of high malaria transmission.
This article presents a qualitative study on acceptance
among caregivers. It is undertaken in parallel with the
trial in Malawi, and explores views on PMC and the five
proposed delivery mechanisms. Since PMC drugs are ad-
ministered to children at home by caregivers, their
awareness and acceptance towards the programme will
greatly influence level of drug uptake.
Qualitative study on acceptance and feasibility of PMC
No qualitative study has been published that investigated
the acceptance of antimalarial drugs given as PMC.
PMC is a malaria control strategy where antimalarial
drugs are given as intermittent preventive treatment to
children after discharge from the hospital. Intermittent
preventive treatment (IPT) targets at-risk patients in
areas of moderate-to-high malaria transmission, and evi-
dence from previous clinical trials has resulted in recom-
mendations from WHO to administer IPT to pregnant
women (IPTp), infants (IPTi) and young children (IPTc)
[6–8]. IPTp is delivered during antenatal care visits,
whilst IPTi is administered to infants through the Ex-
panded Programme of Immunisation (EPI) - and qualita-
tive studies have shown high acceptance among
providers and users in both programmes [9–11]. In the
case of IPTc – or seasonal malaria chemoprevention
(SMC) – no clear guidelines on treatment delivery have
been developed. SMC targets a large group of children
regardless of present malaria status, and is less applic-
able to local settings since these children have limited
contact with the health system. However, previous clin-
ical trials have shown high uptake of SMC when deliv-
ered by village health workers or volunteers at
community level [12, 13].
Caregivers in study arms 2 and 5 in the delivery imple-
mentation trial receive a text message reminder when
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the treatment course is due. Network and mobile phone
coverage is improving in sub-Saharan countries and the
use of mobile and wireless technologies in health care
(mHealth) has the potential to enhance access and ad-
herence to treatment [14]. In paediatric malaria treat-
ment, discordant evidence on the effectiveness of text
message – or Short Message Service (SMS) – has been
presented. A short, informative text message reminder
has proven to increase level of adherence to antimalar-
ial treatment among children [15] while other studies
show little difference in adherence between
SMS-intervention and control groups [16, 17]. A quali-
tative study from Kenya detected high level of accept-
ance among caregivers towards use of text-messages in
malaria treatment of children [18]. Extensive phone
ownership, network availability and literacy was re-
ported as enabling factors, but the text message inter-
vention was not applied to the local setting for
continued investigation. Do caregivers in the PMC trial
consider text message reminders to be applicable in a
real-life rural Malawian context?
In study arm 3, caregivers are supposed to be visited
by a community-based Health Surveillance Assistant
(HSA) one or two days before each of the treatment
courses. Previous studies on SMC have shown how in-
volvement of community-based health workers positively
affects drug uptake [12, 13]. The Malawian Ministry of
Health hires HSAs to provide health promotion activities
in rural and urban communities with populations of
1000 people or more. In prior qualitative studies, HSAs
report a set of multifaceted challenges impairing their
motivation and work performance [19, 20]. These chal-
lenges include supply shortages, heavy workload, lack of
supervision and limited financial incentives. What are
the perceptions of caregivers on the accountability of
HSAs and the feasibility of reminder visits?
Adherence to preventive malaria treatment may be
challenged by caregivers who question the value and ne-
cessity of giving drugs to children who seemingly appear
healthy and have not been tested for malaria [21, 22].
Lack of preceding laboratory and screening assessments
leads to uncertainty of treatment rationale - and care-
givers may find it difficult to understand the importance
of giving drugs as a preventive measure. How do
caregivers in the PMC trial view the value and effective-
ness of preventive malaria treatment?
Methods
Study setting
Study participants (n = 375) in the clinical parent study
are recruited from 1480 villages in the catchment area of
Zomba Central Hospital in the Zomba district of
Malawi. The district has an estimated population of
about 970,000 inhabitants. The majority of study partici-
pants reside in rural communities and their caregivers
mainly perform subsistence farming or are involved in
small-scale businesses (Table 2). In Malawi, primary
school is grade 1–8 and secondary school is grade 9–12.
26% of women and 36% of men age 15–49 have at least
some secondary education. In rural areas, 14% of women
have never attended school, and only 1% attended more
than secondary school compared with 12% in urban
areas [23]. In our sub-study, 14.1% attended secondary
school and the remaining 85.9% only had primary
schooling. 53 out of 64 informants reported to be literate
during enrolment to the main study. Malaria transmis-
sion in the Zomba district follows a perennial pattern
with especially high transmission during the rainy season
from November until April.
Sample selection and data collection
Methodically, this study has a qualitative, exploratory
and interpretative design [24]. From October to Decem-
ber 2016, 30 semi-structured in-depth interviews (IDIs)
and 5 focus group discussions (FGDs) were conducted
with caregivers of children in the clinical trial. Most par-
ticipants in research interviews were female caregivers
whose children recently completed the study.
Data collection tools were reviewed and refined by the
first, second and last author before and during fieldwork.
All interviews and focus groups were conducted in the
local language Chichewa. Informants were purposively
and strategically selected to ensure a wide range of
urban-to-rural areas of residence, although the majority
lived in rural areas. The objective of the qualitative re-
search interviews was to elicit information on percep-
tions of PMC and the five delivery strategies. IDI guides
consisted of open-ended questions on decision-making
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at household level, preferred method of drug delivery,
economic concerns and views on preventive malaria
treatment. Six caregivers in each study arm were se-
lected to take part in IDIs. The second author (BK) con-
ducted all IDIs in the homes or villages of caregivers.
These locations are thought to be well-suited for disclos-
ure of personal views on subjective and sensitive themes.
SS took ethnographic field notes during all IDIs to
describe interview setting and capture non-verbal obser-
vations. This supplementary data enhanced our under-
standing of the study context where beliefs, concerns
and preferences of informants were shaped.
After finishing the IDIs, FGDs with 5–10 participants
from each study arm were arranged. Participants were
selected from the group of remaining caregivers that had
not been included in IDIs. They were invited to attend
FGDs through phone calls or in-person visits. Analysis
of incoming data from IDIs generated interesting themes
and trends which were further investigated during FGDs.
Thus, results from in situ analysis of IDIs were used to
sharpen topics for the FGD guide. FGDs had a special
focus on comparing the benefits and barriers of the dif-
ferent delivery and reminder systems. All FGDs were
conducted at Zomba Central Hospital by one facilitator
and two note takers who are all native speakers of the
local language. The hospital was an appropriate location
for collecting perceptions on less sensitive topics, and lo-
gistically convenient considering the many villages repre-
sented within the groups. Participants received
refreshments and travel reimbursement. The first author
was present during all interviews and group discussions.
IDIs and FGDs were recorded, transcribed verbatim and
translated to English by three research assistants. Thor-
ough quality checks on a random sample of transcripts
were done prior to data analysis by comparing tran-
scripts to audio recordings.
Data analysis
English transcripts were imported into the coding soft-
ware programme NVivo Version 11. Iterative and
detailed transcript readings allowed a gradual familiarisa-
tion with and immersion into the data material. The-
matic analysis followed the framework approach with
pre-defined codes developed a priori on the basis of
study aim, which were further supplemented by codes
emerging from data analysis [25, 26]. Both deductive
and inductive codes were included in a NVivo coding
set. During flexible, recursive and interpretative analysis,
text segments of interest were compared, contrasted and
attached to appropriate codes. The data analysis was
process-oriented and took place both during and after
fieldwork through briefing sessions and discussions
within the research team. This analytic path has facili-
tated extraction of meaning and discovery of regularities,
similarities and divergence in the data material.
Ethical considerations
Ethical approval for the PMC trial and its sub-studies
was granted from the College of Medicine Research and
Ethics Committee (COMREC) and the Pharmacies and
Poisons Board of Malawi, as well as the Regional Com-
mittees for Medical and Health Research Ethics in
Norway. During enrolment to the main study, a written
informed consent was obtained from all caregivers of
study participants. Additionally, a new written informed
consent was collected from caregivers selected for quali-
tative interviews and group discussions. In cases of low
literacy, informants would sign with a thumbprint or a
witness signed on behalf of the informant. One consent
form was kept by study staff, whilst another was given to
the informant. All informants were masked with study
ID numbers to ensure anonymity during IDIs and FGDs.
Statements included in this article carry no personal
identifiers. Data material is securely stored, and can only
be accessed by study staff.
Results
In this section we explore how caregivers consider bene-
fits and barriers of community- and facility-based deliv-
ery of PMC (Table 3), and their thoughts on use of
health card, text message reminders or HSA visits to re-
member treatment dates (Table 4).
Facility- versus community-based delivery of PMC
During research interviews and discussions, the issue
of transportation emerged as a potential barrier of
facility-based delivery. Nearly all informants live in
rural, hard-to-reach areas of the Zomba district. On
their way to the hospital, they often walk in addition
to utilising various modes of transport; like bicycle
taxis and minibuses. Roads can be narrow, bumpy
and in some places non-existent - and during the
rainy season navigation is especially difficult. Never-
theless, according to informants the main hurdle in
Table 2 Informant characterstics in % and n (total = 64)
Age Marital status Education (grade) Number of children Occupation Hours to hospital
< 20 3.1(2) Single 9.4 (6) 1–4 25 (16) 1–3 51.6 (33) Farmer 68.8 (44) 1–2 65.6 (42)
20–30 54.7 (35) Married 71.9 (46) 5–8 60.9 (39) 4–6 37.5 (24) Trader 23.4 (15) 2.5–3.5 25 (16)
> 30 42.2 (27) Divorced 18.7 (12) 9–12 14.1 (9) 7–9 10.9 (7) Other 7.8 (5) > 4 9.4 (6)
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the facility-based study arms was lack of money to
cover travel expenses. Many caregivers tackled this
issue by doing extra labour or selling belongings.
When pre-defined drug collection dates were near,
they would strategically plan how to gather sufficient
amounts of travel money:
“The challenge I was facing was money. As you can see
in this village – money is a problem. Sometimes you
have to do some piecework in the farm or sell your
chicken if you have one so that you can find some
money for transport. If you do not have anything then
you are in big trouble. So when you are supposed to be
going to the hospital you get worried about how you
are going to travel. You try to borrow money and if
you have chickens you sell them to make the journey
possible.” (Mother in arm 5, IDI)
Some caregivers were forced to borrow money from
friends and relatives, and had problems paying back:
“Going to the hospital was a challenge to me because
of the transportation expenses. Sometimes I had
difficulties paying back the money I borrowed.”
(Mother in arm 4, IDI)
On drug collection dates, caregivers often used several
hours of the day on travelling. For some, absence from
home left work responsibilities untouched and children
unsupervised. Many brought their youngest children
along for the journey if no one could watch them at
home. When roads were difficult and the weather was
unpleasantly hot this journey became tiring for both
the child and its caregiver. Still, some willingly
brought their children along with the intention of
seeking follow-up care at the hospital. They saw it as
a chance to maintain ongoing dialogue with hospital
staff and ask questions if necessary. Thus, a strength
of facility-based drug delivery was increased follow-up
care and continuing contact with health personnel.
Additionally, a few caregivers emphasised the value of
drugs being stored at the hospital. They believed
drugs should not be kept at home for an extensive
period of time since this may threaten durability and
effectiveness of the drug, whereas a hospital pharmacy
provides a safe space for drug storage:
“It is better to collect medicine from the hospital
considering that care for the medicine at the village
may be hard with the houses we live in. Some of us
stay in leaking houses so the medicine may even be
soaked (…) and then we give it to the child. In this
way you are giving a medicine that is not good to the
child.” (Father in arm 4, FGD)
Despite the benefits of strengthened follow-up care
and safe drug storage, most informants in facility-based
study arms spoke in favour of drug delivery through a
Table 3 Reported benefits and barriers of facility- and community-based delivery of PMC
Main findings Facility-based delivery Community-based delivery
Benefits * More contact with health personnel
* Possibility of follow-up care at the hospital
* Safe drug storage at hospital pharmacy
* Easy home access to drugs
* Less financial concerns
* Less worries related to
care of children
* More time for work tasks
Barriers * Travel expenses
* Extra work burden
* Long travel distance
* Challenging roads
* Perceived negative effect of longtime
home drug storage on drug durability
Table 4 Reported benefits and barriers of text message reminder, visit from HSA and exclusive use of health card
Main
findings
Text message reminder Visit from HSA Exclusive use of health card
Benefits * Extra assurance
* Reminder is sent directly
to caregiver
* Face-to-face interaction
* Assistance and counseling
* Active use of health card and memory
* Strengthens self-reliance
* Establishment of nearby reminder- and
support system
Barriers * Lack of phone
* Prolonged delivery of text message
via substitute phone owner
* Network and electricity problems
* Limited understanding of text
message content due to low literacy
* HSA unreliability
* Long distance between home
of study participant and HSA
* Reminder from the hospital goes via a HSA
and is not transferred directly to the caregiver
* Challenges with remembering treatment dates
* Limited understanding of health card content
due to low literacy
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community-based approach. They claimed that their
concerns about the cost, time and risk of travelling to
the hospital would mitigate if all drugs were collected at
the hospital before discharge. Easy home access to drugs
would ensure increased flexibility in matters of care and
work:
“We always face challenges when it comes to issues of
transportation in this area. To get to the hospital we
need money for transportation and we have to travel a
long distance to get to the hospital. After collecting the
drugs we have to travel the same distance back home.
This is why I prefer collecting all the drugs at once.”
(Mother in arm 5, IDI)
“Collecting all the drugs and having them at home is a
good idea because when you do so you avoid a lot of
things. If it happens that you do not have money for
transportation on the day that you are supposed to go
to the hospital to collect the drugs you don’t need to
worry because you have everything that you need right
there at home.” (Mother in arm 2, FGD)
“I was not finding any chance to do chores at home
because I was waking up very early in the morning and
there was no time to do anything else than going to the
hospital to collect drugs.” (Mother in arm 5, IDI)
A commitment to comply with treatment guidelines
was evident among informants in both community- and
facility-based study arms. Regardless of assigned delivery
method, informants were dedicated and determined to
follow instructions. Almost exclusively, they shared posi-
tive views on the trial drug and its effectiveness. Add-
itionally, the appreciation and admiration towards health
personnel at Zomba Central Hospital was apparent.
Hence, economic constraints and other barriers did not
overshadow their motivation to come for drug collection
at the hospital. Still, most informants considered drug
delivery at discharge less challenging both financially
and personally. When asked to rank one method above
the other, a clear majority preferred community-based
delivery of PMC.
Text message reminder versus visit from health
surveillance assistant
In study arms 2 and 5, caregivers are supposed to be
reminded via phone text message on days of drug ad-
ministration or collection. Some informants described
text messages as a “quick” and “easy” way of conveying
reminders directly to caregivers. For them, it functioned
as reassurance and encouragement on treatment dates:
“I think the text message is a very good approach
because sometimes you may get busy and forget.”
(Mother in arm 5, FGD)
Nevertheless, numerous barriers to the use of text mes-
sage reminders were reported. A recurring theme was the
challenge of phone usage. Informants persistently stressed
how lack of electricity, inadequate charging services and
network problems impede their ability to receive text mes-
sages. Another frequently expressed obstacle was phone
availability. Several caregivers do not own a phone and re-
minders were sent to the phone of a relative, neighbour or
friend instead. In these instances, the message was often
conveyed via multiple intermediate carriers before finally
arriving with the caregiver. Thus, the passing of informa-
tion could be disturbed, prolonged and, in some cases,
permanently halted:
“Some of us do not have our own phones. We rely on
other people’s phones to receive these reminders.
Relying on phones may become a problem if the owner
of that phone is not around and the message does not
get to you in time.” (Mother in arm 2, FGD)
“My in-law received the reminder messages and would
call one of the girls who lived right here in the commu-
nity, and the girl would pass on the message to me.
However, the girl who had the phone has now moved.”
(Mother in arm 2, IDI)
In study arm 3, caregivers are supposed to be visited
by a Health Surveillance Assistant (HSA) when the treat-
ment course is due. HSAs in Zomba district were
instructed on their role in the PMC programme during
briefing meetings held at local health centres before
study initiation. The HSAs are supposed to act as
message-carriers between health staff at hospital level
and caregivers at community level.
Informants attached varying attributes to the HSAs dur-
ing interviews and discussions. Some characterised them
as lazy and negligent, whilst others shared an appreciation
of HSAs and described them as helpful and generous.
Caregivers in the HSA study arm acknowledged both ben-
efits and barriers of this reminder strategy. They under-
stood that the primary purpose of a HSA visit was to
remind them on treatment dates, and some claimed that
it also allowed exchange of questions and knowledge on
malaria and other under-five childhood illnesses. The visit
provided some of the caregivers with a sense of assurance
that drugs were administered in a correct manner, and
they addressed how a face-to-face interaction is prone to
less misunderstanding than technology driven phone and
text message communication:
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“When the HSA visit and we sit together it is possible
to understand each other. You and I are sitting here
and if there is something I do not understand I can
ask “what did you say there?” but you cannot ask that
through the phone, maybe I do not have airtime to
call and ask for guidance.” (Mother in arm 3, FGD)
“A phone is both reliable and unreliable as well, like
today they can send a message and remind me to give
drugs to the child and the next day I will not be
available maybe because a charger is broken or the
battery is dead. There are electricity problems also
and that is what we experience – so a phone is a bit
hard to use and it will be better if the HSAs visit and
remind us verbally.” (Mother in arm 3, FGD)
Nonetheless, a widely reported barrier was the unreli-
ability of HSAs. Many caregivers in the HSA study arm
mentioned the unavailability of HSAs in their catchment
area and lack of home visits by the designated HSA.
While some informants reported being visited by the
HSA either one or three times during the study period,
most stated that they received no visits but still remem-
bered to give medicine to their children:
“The HSA did not visit me even once. However, I gave
my child the drugs according to the instructions in the
book (health card) and I did not miss (…) I felt like the
HSA neglected us because he did not even call me, so I
just calculated the dates and numbers in my head.”
(Mother in arm 3, FGD)
“Since the medicine was already here, I just took it
and gave it to the child considering that the HSA who
is working may be busy with other things so if we are
waiting to be told we will end up not giving the
medicine to the child.” (Mother in arm 3, IDI)
When informants across all study arms were asked to
compare the two reminder strategies, the majority
ranked text messages as their preferred method. They
wanted reminders to be sent directly to them instead of
going through a HSA:
“I would recommend the mobile phone approach
because in this way the reminder will come directly to
me.” (Mother in arm 3, IDI)
Although many informants were positive towards the use
of text message reminders, the success of this model de-
pends on whether conditions are favourable and caregivers
own well-functioning phones. In theory, text messages are
quick and efficient sources of information – but experiences
from caregivers suggest that a tech-dependent reminder
system in the current rural Malawian setting is difficult:
“I would prefer using the phone because it is quicker
(..) but it is just that the battery on my phone has a
problem so it is unreachable.” (Mother in arm 3, IDI)
Reminders versus relying on health card and memory
Every child in the trial has a national public health card
where dates for PMC treatment courses are written. In
study arms 1 and 4, caregivers receive verbal instructions at
the hospital and are supposed to remember the dates them-
selves. Caregivers in these study arms repeatedly checked
the health card and they often asked a spouse, relative or
friend to remind them when treatment dates were ap-
proaching. Thus, they created their own reminder- and sup-
port system of people with the child’s best interest at heart:
“On one of the days I nearly forgot to give the drug to
the child because I was busy but my husband
reminded me.” (Mother in arm 4, IDI)
During IDIs and FGDs, caregivers in all five study
arms were informed on the various delivery strategies
and asked to compare and decide their preferred
method. The great majority shared positive attitudes to-
wards use of a health card to remember treatment dates,
and a high number of informants insisted they could be
self-dependent and administer drugs to their children
without reminders:
“The most recommendable approach would be the one
where all information is written in the health card. In
that way I would always remind myself by constantly
checking the dates.” (Mother in arm 3, IDI)
Caregivers claimed that information in the health card
was easily accessed due to its constant presence at home,
and since it contains important health-related information
they would usually keep it in a safe place. Many caregivers
who were supposed to receive reminders reported that
they would administer drugs according to health card in-
structions even in the absence of reminders. Hence, active
use of the health card evoked an inherent sense of inde-
pendence and self-reliance among caregivers:
“The health card is a good approach because when
you have all the information in the health card you
don’t have to rely on someone to remind you about the
dates. Sometimes you may wait for a text message
which may never come and this becomes a problem to
your child.” (Mother in arm 2, FGD)
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A few caregivers reported low literacy as the only po-
tential challenge to the use of health card. In their opin-
ion, those who had never gone to school or spent a few
years in primary school would have difficulties under-
standing content in both the health card and text mes-
sages. Nevertheless, many informants argued that it was
easy for those with limited primary school education to
find a family member or friend who could read the
health information for them. The many positive percep-
tions on use of health card and memory show how care-
givers want to take responsibility for the collection and
administration of drugs to their children:
“I would recommend the method where I can remind
myself about the time to give the drug to the child. I
don’t think waiting for someone to remind me would be
recommendable because they may one day forget and
the child will not get the drug that day (…) I can’t get
used to the fact that someone has to come to remind me
about the dates of giving the drug to the child – I have
to do that on my own.” (Mother in arm 4, IDI)
“The best is to write in the book (health card) because
HSAs have their own problems to think about. Maybe on
the day they were supposed to remind you, they have
gone for training. This means that you will not be
reminded. While with the text messages – the message
may be sent but at that time the phone is off and you
will see it after two days. With the book (health card) you
can easily refer to it anytime.” (Father in arm 4, FGD)
Self-reported compliance and views on preventive
malaria treatment
A high degree of self-reported compliance was discov-
ered among informants. Only a few stated that they
missed a treatment date, and several factors might have
contributed to the high level of compliance. Caregivers
had recently experienced how severe anaemia detrimen-
tally impaired the health and well-being of their chil-
dren. After this experience they are familiar with the
symptoms, severity and dangers of the disease, and the
past event generated a feeling of fear which functioned
as a driving force for treatment compliance:
“I had the memory of how my child was sick and the
stage he reached. So I made it a point not to belittle
the medicine, but to give them to him every day until
the dosage was finished so that I could see how helpful
the medicine was.” (Mother in arm 1, IDI)
During enrolment to the trial, health staff instructed
caregivers on drug administration and underlined the
importance of following treatment guidelines. Most in-
formants described how they would give the drugs in
the morning at the same time for three consecutive days.
Also, they fed their children before giving the drugs.
These findings indicate that caregivers had a good un-
derstanding of information provided at the hospital. In
addition, informants claimed that a facilitating factor for
drug adherence was regular follow-up visits. A member
of study staff visited the participant’s home to do pill
counts after each treatment course. The expectation of
these encounters could have unrealistically enhanced
treatment adherence. Thus, context and circumstances
of the trial setting might have contributed to the high
level of acceptance and self-reported compliance among
caregivers.
Overall, informants were positive towards participation
in the programme. The DHP drug was considered safe
and effective due to its observed impact on the health
status and well-being of study participants. Caregivers
reported improvement in the health, appetite, mood, en-
ergy level and appearance of their children. When asked
about potential barriers to participation, they mentioned
transport costs and logistic difficulties in facility-based
delivery and the risk of longtime home drug storage in
community-based delivery. Consequently, some sug-
gested storing and distributing drugs at local health fa-
cilities instead of the hospital:
“It is important that antimalarials are given to children
when they have been discharged from the hospital, but
they should not let the caregivers travel all the way to
the hospital to collect the drug for the sake of those who
live far away (…) It is better to have the drugs at the
nearest health facility where they can be cared for and
easily accessed.” (Mother in arm 5, IDI)
Scepticism and superstition among neighbours and
other village members was also reported by a few infor-
mants as complicating factors for participation:
“People should continue to give the drugs despite of
what other people say. Some people insinuate that if
your child is taking the antimalarial drugs it means
they are HIV-positive. I did not care what people said
because I knew my child needed help and the drug
had nothing to do with HIV.” (Mother in arm 5, IDI)
“When I went home after being discharged from the
hospital, some of the people in the village told me that
I had involved myself into Satanism by enrolling my
child in this programme. But I took the document
which I was given at the hospital and gave it to them
as evidence for what I was really involved in. I also
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explained that my child was sick and right now he
was put on a dosage of antimalarial drugs so therefore
I will be going to the hospital to collect the drugs.”
(Mother in arm 5, FGD)
In some cases, resistance among community members
was rooted in limited understanding of the necessity of
giving drugs to children who appeared healthy and were
already discharged from the hospital:
“There are some women who are afraid to put their
children on more antimalarials simply because they
have already been treated at the hospital and they are
doing much better. However, they do not know that
this is something that can be of much help to their
children.” (Mother in arm 2, FGD)
After witnessing the beneficial effects of the drugs
themselves, caregivers tried to abolish other people’s dis-
trust by showcasing the health improvement of their
children, and by sharing their acquired knowledge on
the value of preventive malaria treatment:
“I would tell other caregivers not to be discouraged
if they are asked to take part in the programme (…)
they should not be afraid or think that they will be
given a difficult or bad medicine. All they (health
staff ) want is for your child to be well (…) my child
was part of this and she has strength now.” (Mother
in arm 4, FGD)
“Since we don’t know where the illness is hiding the
antimalarial drugs are a good thing because they act
like a shield and are really protecting the child.”
(Mother in arm 2, IDI)
Another suggested strategy for battling resistance,
reluctance and rumours was sensitisation meetings di-
rected by health staff or HSAs at community level.
Informants stated that such meetings could increase
awareness and acceptance of the programme, and sev-
eral informants highlighted the importance of includ-
ing village heads since they usually have great
influence and authority in their respective communi-
ties. Additionally, many noted that they – as care-
givers of children in the programme - should
function as role models and share their experiences
with other caregivers:
“I can be of help in this programme because I have
been part of it so I can encourage my friends after
having experienced the goodness of malaria
prevention.” (Mother in arm 5, IDI)
“I can help my fellow women with an orientation on
how the drug should be given to the child. I would also
use my situation as an example and share my
experiences on how I gave this drug to my child.”
(Mother in arm 2, FGD)
Discussion
In contrast to IPTp, IPTi and SMC (IPTc), the PMC
(IPTpd) programme is directed towards a smaller popu-
lation of seriously ill patients. These patients have
already established connections to health staff after a re-
cent hospital admission, and PMC is therefore perceived
as a “natural” continuation or follow-up treatment and
results from this qualitative study show that it is
well-accepted among caregivers. Even though their chil-
dren seem healthy, caregivers in the programme under-
stand the value of giving preventive malaria drugs in the
post-discharge period. The fear of reliving past experi-
ences where their children suffered from severe malarial
anaemia seems to function as a driving factor for treat-
ment adherence. Also, caregivers share their experiences
from the programme with community members and
thus contribute to increased general acceptance towards
PMC. Our findings support a previous study which
showed high caregiver acceptance of DHP in malaria
treatment of young children in Malawi [27].
Focus and dedication towards the programme is easily
detected among caregivers and other individuals closely
related to the child. Conversely, those with less emotional
attachment to the child are likely to not have the same de-
gree of interest in the child’s health improvement and
treatment dates. For this reason, caregivers should not de-
pend entirely on relatives, neighbours or friends to remind
them. This may pose a threat to the accuracy and timeli-
ness of drug administration. Neither should they rely com-
pletely on a text message which they may not receive due
to phone problems, or a HSA visit which they may not re-
ceive for other reasons. Depending heavily on reminders
can hamper their own efforts to remember treatment
dates and threaten their sense of responsibility in the
programme. Enabling and blocking factors of both re-
minder models have been presented, and the main barrier
in the HSA study arm was lack of reminder visits. This
might be explained by the heavy work load of HSAs which
led them to either forget or choose to not prioritise the
visits. HSAs are supposed to receive a text message with
instructions from study staff, and faults in this communi-
cation pathway can also explain the lack of visits. Add-
itionally, the willingness of HSAs to adhere is possibly
limited by the fact that they receive no additional remu-
neration for doing reminder visits.
Furthermore, we see that most caregivers prefer text
message reminders rather than HSA visits. Preferably, the
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reminder should be sent directly to their personal phones.
If this is not possible they should live in close proximity to
the substitute phone owner. Those who struggle with re-
membering treatment dates may find the reminder im-
perative, while the ones already aware of the dates regard
it as a convenient confirmation of less importance. Hence,
caregivers do benefit from the support of reminders - but
they also benefit substantially from investing energy and
effort into active use of the health card in order to remem-
ber treatment dates on their own. Our most surprising
finding is the high acceptance towards exclusive use of the
conventional, old-school health card with recorded treat-
ment dates and medical history. Among informants, this
card is regarded as a valuable treasure-like object that
must be taken good care of.
Study limitations
Data collected during qualitative research interviews and
discussions is prone to social desirability bias [28]. Par-
ticipants may have a desire to respond positively in order
to please interviewers or secure future support from
hospital staff. Also, responses might have been affected
by recall bias although most caregivers had participated
in the programme recently.
There was a mix of male and female participants in 3
of 5 FGDs, while most IDIs only included female care-
givers. A greater inclusion of male caregivers could have
expanded the range of viewpoints in the data material.
The number of IDIs and FGDs conducted in each study
arm was predetermined based on available time and fi-
nancial resources. We did not know in advance whether
a point of data saturation would be reached, but daily
briefing sessions and data analysis performed during
fieldwork assured us that saturation was achieved and
no additional interviews were added.
The level of acceptance and awareness towards PMC
may be higher in this trial compared to a non-trial set-
ting with limited follow-up and less instructions from
health staff. Our results are drawn exclusively from
qualitative research interviews and discussions, and it re-
mains to see whether findings from the main study will
mirror the high degree of self-reported compliance
found in this study. Other ongoing sub-studies will bring
forth evidence on cost-effectiveness, drug uptake levels
and clinical outcomes.
Conclusions
Our findings reveal a high degree of acceptance towards
malaria chemoprevention given as post-discharge man-
agement of children treated for severe anaemia. Receiv-
ing all drugs before discharge is perceived as more
acceptable than collecting drugs for each treatment
course at the hospital. Text messages are viewed as a
more feasible strategy for reminding caregivers of
treatment dates than visits from Health Surveillance As-
sistants. Nevertheless, the success of both reminder sys-
tems is challenged by complicating factors in the rural
Malawian context.
Our findings indicate that the national health card is
the most secure, reliable and easily accessible tool for
health related information. It is viewed as the unwaver-
ing source of information on treatment dates and the
majority of caregivers use it as their primary tool of ref-
erence. Exclusive use of the health card has the advan-
tage of not adding extra costs to caregivers or the health
system. In a possible future implementation of
post-discharge malaria chemoprevention (PMC), care-
givers should be informed on the importance of their
commitment for the success of this treatment. If care-
givers are conscious about their pivotal role in the
programme it will strengthen their willingness and mo-
tivation to comply.
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